Humanitarian Crises: Ongoing conflicts and natural disasters displacing millions of people worldwide. Calls for international cooperation and increased humanitarian aid to address these crises.
Space Exploration: Successful landing of China’s Zhurong rover on Mars, marking the country’s second successful interplanetary landing. Continued international cooperation in space exploration, with upcoming missions to the Moon and beyond.
Social and Political Movements: Continued protests and activism around the world on issues like racial justice, climate change, and women’s rights. Political and social tensions in various countries, including Peru, Iran, and Israel.
Public Health Developments: Ongoing response to the COVID-19 pandemic, with new variants and debates over booster shots. Progress in research for treatments and vaccines against other diseases, such as malaria and HIV/AIDS.
The real estate market in Dubai is looking to recover with the search for Israeli investors.
Technological Advancements: Breakthroughs in artificial intelligence, renewable energy, and space exploration. Continued development of ChatGPT and other AI language models, advancements in solar and wind power technology, and successful launch of NASA’s Artemis mission to the Moon.
Economic Uncertainty: Rising inflation and interest rates impacting global economies, leading to concerns about a potential recession. Central banks raising interest rates to combat inflation, with consequences for businesses and consumers.
Global Climate Change: Record-breaking heatwaves and wildfires in Australia, severe storms and flooding in California, highlighting the urgency of climate action. Ongoing international climate negotiations and domestic policies aimed at reducing greenhouse gas emissions.
US Supreme Court Ruling on Affirmative Action: Supreme Court hears arguments in two cases challenging affirmative action in college admissions and contracting. Potential for a landmark decision impacting racial equality in education and business.
US Midterm Elections: Democrats narrowly maintain control of the Senate, Republicans win majority in the House of Representatives. Potential for divided government impacting legislation and political discourse.
Russia-Ukraine War: Escalation in eastern Ukraine, with Russia capturing Avdiivka, its biggest gain in nine months. Ongoing international sanctions on Russia and humanitarian efforts for Ukraine.

According to a report by IVC, ZAG S&W Zysman, Aharoni, and Gayer & Co, in the second quarter of 2020, Israeli high-tech investments hit a new record, with 170 new investments in the second quarter of the year.

Although the Covid-19 epidemic continues to threaten the global economy, there is some relief regarding Israeli investment in high technology, following its almost natural linear trend. The positive trend continued in the first and final rounds in the first half of 2020, reaching $ 5.25 billion in 312 deals.

Israeli investments – From February to March, the number of financing transactions, especially for early financing rounds, decreased significantly. However, in April and May, the number of transactions for previous rounds followed regular intervals and offset the decline in the first quarter of 2020.

Israeli high-tech companies were successful in the second quarter of 2020, raising $ 2.5 billion through 170 deals. The quarter was the second strongest quarter in terms of total amounts allocated. Although the average amount decreased slightly due to the increase in the lower end of the financing rounds, several bids were submitted.

Biocatch, a company that provides behavioral biometrics, has created a $ 145 million investment.

Vast Data provides cost-effective solutions for flash storage infrastructure and integrates applications into a scalable flash storage system to meet high-performance needs. The company has completed a $ 100 million financing round.

Pagaya, a global fintech company that uses artificial intelligence (AI) to reshape asset management and corporate investment, has completed a $ 102 million round of financing.

Israeli investments in the pharmaceutical sector

There are more than 1,500 companies active in the medical sector in Israel. Along with significant investments in research and innovation, Israel is at the center of some essential health and medical technology developments.

The most obvious example is Teva Pharmaceutical Industries, one of the largest global pharmaceutical manufacturers. At the same time, Israel is also a hub for biotechnology companies, R&D centers, and prestigious academic institutions, emphasizing creativity and innovation.

Doxil (known as Caelyx in Europe and Canada) is the world’s first nano-drug to treat various cancer types, developed by researchers at the Hebrew University of Jerusalem. The Weizmann Institute of Science formulated the revolutionary multiple sclerosis drug Copaxone, one of the first Israeli drugs to receive approval from the US Food and Drug Administration.

In recent decades, Israel has become an integral part of the global pharmaceutical industry, with exports to the United States growing from $ 208 million in 1997 to $ 5.9 billion in 2018.

Here are some examples of innovative companies in Israel in the pharmaceutical sector:

Israeli investments – CytoReason has developed the world’s first and only model of the human immune system and the cells that feed it. Founded in 2016 based on Stanford University and the Technion Institute research, the company has collaborated with reputable organizations such as GSK, Pfizer, and the Parker Institute for Cancer Immunotherapy.


The National Institute of Biotechnology of the Negev (NIBN) has some particular advantages: the first independent research and development center established within a university, Ben-Gurion University of the Negev. The technologies developed by the institute formed the basis for new companies, and applied research has had a tangible effect in the real world, including reducing the infant mortality rate by 30% among Israel’s Bedouin population in the Negev desert.

Dexcel Pharma is the largest private pharmaceutical company in Israel. The company produces both original, proprietary, and public domain drugs. It has over 85 products in over 175 dosage forms, with the company currently having offices with more than 1,000 employees in countries such as the UK, Germany, Singapore, and, of course, Israel.

Israeli investments – With emerging fields such as personalized therapy and the discovery of AI-based drugs designed to transform modern medicine, Israel is in a privileged position to continue to play a vital role in pharmaceutical innovation through technology and innovation.

Recent News & Activity of Israeli investments during the Corona pandemic in technology

Related startups


You know your business better then us. But we are know both sides cualter and interest points we can make your life easier and save your time! and we do it.
Who Are you?

You are beautiful!Congratulations on the end of registration

أنت تعلم عملك أكثر منا. ولكننا نعلم كيف نجعل حياتك أسهل وسنوفر عليك الكثير من الوقت حتى تتابع عملك بنجاح
من أنت؟